DIOS-CoVax clinical trial recruitment and analysis

使用DIOSynVax技术开发了预防多种相关病毒的疫苗。对于SARS-COV-2和SARS-COV等冠状病毒来说，这种广泛的保护性方法是必要的，这两种病毒是许多相关病毒中的两种，有可能导致未来从人畜共患病人群中暴发。我们已经设计了抗原来诱导对肉瘤病毒的免疫反应，以防止目前的大流行和未来相关冠状病毒的爆发。这种疫苗使用一种无针技术，使患者细胞产生抗原，免疫系统识别这些抗原，以诱导对SARS-CoV-2和相关冠状病毒的保护。

Vaccines that protect against multiple related viruses have been developed using DIOSynVax technology. This broadly protective approach is needed for the Coronaviruses such as SARS-COV-2 and SARS-COV, two of numerous related viruses that have the potential to cause future outbreaks from zoonotic reservoirs. We have designed antigens to induce an immune response against the Sarbecoviruses in order to protect against the current pandemic and future outbreaks of related Coronaviruses. This vaccine is administered using a needleless technology causing patients' cells to produce the antigens, which are recognized by the immune system to induce protection against SARS-CoV-2 and related Coronaviruses.